< previous issue
next issue >
Crossing the blood-brain barrier: are we getting it right?
Mouse model for Burkitt's lymphoma will aid understanding and therapy
Welcome to the news
What the industry says
Encapsulated cell technology provides new treatment options
Targets and mechanisms
Hinde A.; Ramster B.; Owens J.; Lawrence R.N.
Craig Venter discusses life after the Human Genome Project - Interviewed by Rebecca Lawrence
David Bentley discusses life after the Human Genome Project - Interviewed by Rebecca Lawrence
Computational approaches in the post-genomic era - how will we cope?
Lahana R.; Church D.J.; Terrett N.
Discovering drugs for heart failure?
Open day review: bridging the gap between academia and industry
Roberts P.J.; Kozlowski R.Z.
Quo vadis, biotech? (Part 2)
Carbohydrate sulfotransferases: novel therapeutic targets for inflammation, viral infection and cancer
Antibody libraries in drug and target discovery
Folate-mediated targeting: from diagnostics to drug and gene delivery
Leamon C.P.; Low P.S.
Monitor: molecules and profiles
Barrett D.; Langston S.
Here are a few pages on the site that we think you may find useful: